Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Innovation Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Innovation FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaHDFC
NAV₹15.4407₹23.6750
NAV date20 Nov 202620 Nov 2026
History3.2 years3.1 years
Expense ratio0.9%1.1%
Stars★★★★★★★★★★
Growth Score46.5094.50

Returns

Nippon India Innovation FundHDFC Pharma and Healthcare Fund
1 month+5.54%+12.97%
3 months−3.05%+7.13%
6 months+8.56%+17.84%
YTD+4.43%+33.73%
1 year+2.54%+32.20%
3 years (CAGR)+13.75%+30.70%
5 years (CAGR)——
10 years (CAGR)——
Since launch+14.13%+31.83%

Risk

Nippon India Innovation FundHDFC Pharma and Healthcare Fund
Volatility17.2%15.8%
Downside volatility11.8%8.5%
Sharpe0.421.53
Sortino0.622.86
Calmar0.642.06
Return / risk0.801.95
Deepest fall−21.47%−14.91%
Days to recover518126
Below its high−3.31%+0.00%

Against benchmark

Nippon India Innovation FundHDFC Pharma and Healthcare Fund
Alpha+1.93%+7.54%
Beta1.000.97
R²88.2%85.0%
Up capture110.0%108.9%
Down capture105.1%71.0%
Tracking error5.9%6.1%
Information ratio0.331.17
Treynor0.060.24

Consistency

Nippon India Innovation FundHDFC Pharma and Healthcare Fund
Best 1-year+51.67%+67.01%
Middle 1-year+6.12%+23.25%
Worst 1-year−7.68%+1.71%
1-year periods with a loss7.3%0.0%
Middle 3-year+13.78%+30.22%
Positive months72.2%72.2%
Best day+4.00%+3.18%
Worst day−3.85%−3.61%
Worst 5% day−1.59%−1.51%
Positive days56.0%58.3%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Innovation FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR+8.25%+27.71%
1-year XIRR+9.91%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth